New York, NY -- (SBWIRE) -- 01/17/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Centrais Eletricas Brasileiras SA (ADR) (NYSE:EBR.B), On Track Innovations Ltd (USA)(NASDAQ:OTIV), Alimera Sciences Inc (NASDAQ:ALIM), Monster Worldwide, Inc (NYSE:MWW)
Centrais Eletricas Brasileiras SA (ADR) (NYSE:EBR.B) showed a volume of 361,335 shares by the end of last trade whereas the average volume of the stock remained 138,805 shares. The stock opened the session at $4.14 but then moved to $3.97. At that price, the stock showed a negative performance of -6.37%. Centrais Eletricas Brasileiras SA (Eletrobras) is a Brazil-based holding company engaged in the electric power generation, transmission and distribution. The Company operates and maintains 36 hydroelectric power plants, 120 thermal power plants, 2 nuclear power plants and 4 wind/solar power plants.
Will EBR.B Get Buyers Even After The Recent Rally? Find Out Here
On Track Innovations Ltd (USA)(NASDAQ:OTIV) opened the session at $4.00 and closed the session at $4.07. The stock showed a positive performance of 2.52% in previous trading session. Traded with volume of 1.12 million shares in the prior session and the average volume of the stock remained 697,971.00 shares. On Track Innovations Ltd. (OTI) designs, develops and markets solutions based on its secure contactless microprocessor-based smart card technology to address the needs of a range of markets. The Company’s products combine the benefits of both microprocessors and contactless cards. In addition, it also sells products that are based on other card technologies.
For How Long OTIV will fight for Profitability? Read This Trend Analysis report
Alimera Sciences Inc (NASDAQ:ALIM) opened the session at $6.00 and closed the session at $7.19. The stock showed a positive performance of 19.04% in previous trading session. Traded with volume of 1.10 million shares in the prior session and the average volume of the stock remained 375,487.00 shares. The beta of the stock remained 1.59. Alimera Sciences, Inc.is a biopharmaceutical company that develops and commercializes prescription ophthalmic pharmaceuticals. The Company advanced product candidate, ILUVIEN, is a tiny, cylindrical polyimide tube that contains 190 g of fluocinolone acetonide (FAc), a corticosteroid with a history of treating ocular diseases.
Why Should Investors Buy ALIM After The Recent Gain? Just Go Here and Find Out
Monster Worldwide, Inc (NYSE:MWW) the stock decreased -2.81% and finished the session at $6.58. Traded with volume of 1.08 million shares in the prior session and the average volume of the stock remained 2.48 million shares. The beta of the stock remained 2.78. Monster Worldwide, Inc. (Monster Worldwide) is parent company of Monster, the global online employment solution. With a presence in approximately 55 countries globally, including key markets in North America, Europe, South America and the Asia-Pacific region,
Will MWW Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)